Delivery Order SPE2DB20D3101-SPE2DB25FRSV5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,248.36 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed-price, competitively awarded contract was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Mestinon is a pharmaceutical product used in the treatment of myasthenia gravis and related...
- The Defense Logistics Agency awarded a $3,998.11 delivery order to AmerisourceBergen Drug Corp for Mestinon 180 mg Timespan in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, featuring an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its Corporate Office location in Conshohocken, PA 19428. This...
- The Defense Logistics Agency awarded a $5,900.40 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $7,037.30 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of August 14, 2025. The contract is performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,667.30 by the Defense Logistics Agency's Medical Supply Chain on August 8, 2025, for the supply of Mestinon 180 mg Timespan in units of 30 tablets. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,963.15 firm-fixed-price contract is for the supply of Mestinon 180 mg Timespan medication. This delivery order falls under a larger Indefinite Delivery Contract with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which provides a wide range of pharmaceutical and medical supplies to military treatment facilities and...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MESTINON 180 MG TIMESPAN UU 30S, a prescription medication, with a ceiling value of $5,620.37. The contract is a firm fixed price arrangement with a performance period extending through June 16, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MESTINON 180 MG TIMESPAN UU 30S medication. The contract has a firm fixed price of $5,440.14 and a completion date of May 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,580.25 firm fixed-price delivery order is for the supply of Mestinon 180 mg TimeSpan medication and has an ultimate completion date of December 12, 2024. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,254.70 firm fixed-price delivery order is for the supply of 4,564,960 tablets of the medication Mestinon 60 mg. The contract has an ultimate completion date of June 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRSV5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,496.72 to AmerisourceBergen Drug Corp for Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed price, non-set-aside contract was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which serves as the primary pharmaceutical supply vehicle for military healthcare systems. Mestinon (pyridostigmine bromide) is a medication used to treat myasthenia gravis and other neuromuscular conditions, representing the type of specialized pharmaceutical products that AmerisourceBergen Drug Corp routinely supplies to support Department of Defense medical requirements. As a major pharmaceutical distributor and critical vendor in the federal medical procurement supply chain, AmerisourceBergen Drug Corp has demonstrated consistent capability to meet competitive federal procurement standards across a diverse portfolio of therapeutic domains, including neurological treatments, pain management, and specialty medications for military and veteran healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/18/25 |